Covid-19: Oxford vaccine could be 59% effective against asymptomatic infections, analysis shows
Elisabeth Mahase
Abstract
Covid-19: Oxford vaccine could be 59% effective against asymptomatic infections, analysis shows Elisabeth MahaseThe Oxford and AstraZeneca covid-19 vaccine prevented some asymptomatic covid-19 infections in phase III trials, but the effect was mainly seen in the group who received a half dose first, followed by a full dose, the peer reviewed efficacy results have shown. 11
Topics & Concepts
AsymptomaticCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAsymptomatic carrierClinical trialVirologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19